Clinical Trials · NCT00672074
Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Helsinn Therapeutics (U.S.), Inc
- Enrollment
- 117
- Start date
- Apr 2008
- Locations
- 19 sites, United States
- Primary endpoint
- Recovery of GI function